( NYSE:GSK,NYSE:PFE )

News from ViiV Healthcare A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 22, 2013, 09:00 ET Tivicay® (dolutegravir) receives positive CHMP opinion in Europe for the treatment of HIV

 ViiV Healthcare today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has...


Oct 22, 2013, 12:53 ET ViiV Healthcare announces US regulatory submission for a single-tablet regimen combining dolutegravir with abacavir and lamivudine for people living with HIV

ViiV Healthcare today announced the submission of a regulatory application in the United States for its investigational single-tablet regimen (STR)...


Sep 12, 2013, 18:22 ET ViiV Healthcare Presents Positive Data from Phase IIIb/IV Study of Dolutegravir vs Darunavir in Treatment-Naive Adults with HIV-1

 ViiV Healthcare today announced initial results from the Phase IIIb/IV FLAMINGO (ING114915) study. This open-label study, for the first time,...


Sep 04, 2013, 09:00 ET ViiV Healthcare Expands HIV/AIDS Community Support in Hard-Hit Southern U.S.

 ViiV Healthcare announced today the first Positive Action Southern Initiative (PASI) grant awardees in Texas and Virginia and seven grant...


Aug 14, 2013, 19:16 ET ViiV Healthcare anuncia la aprobación de Tivicay® (dolutegravir) en EE. UU. para el tratamiento del VIH-1

ViiV Healthcare tiene el gusto de anunciar hoy que la Administración de Drogas y Alimentos (Food and Drug Administration, FDA) de los...


Aug 12, 2013, 22:54 ET UPDATE: Multimedia Assets Now Available: ViiV Healthcare announces U.S. approval of Tivicay® (dolutegravir) for the treatment of HIV-1

ViiV Healthcare is pleased to announce today that the U.S. Food and Drug Administration (FDA) has approved Tivicay® (dolutegravir) 50-mg...


Aug 12, 2013, 20:48 ET ViiV Healthcare announces U.S. approval of Tivicay® (dolutegravir) for the treatment of HIV-1

ViiV Healthcare is pleased to announce today that the U.S. Food and Drug Administration (FDA) has approved Tivicay® (dolutegravir) 50-mg...


Nov 08, 2012, 03:30 ET ViiV Healthcare commits nearly £4M in Positive Action for Children Fund grants for programmes focused on alleviating burden of HIV on women and children

ViiV Healthcare announced today that it has awarded nearly £4 million to 99 projects in 26 countries through its Positive Action for Children...


Jul 18, 2012, 04:00 ET ViiV Healthcare Expands Commitment to Addressing Gaps in Paediatric HIV Research, Care and Treatment

ViiV Healthcare today announced a broad range of groundbreaking initiatives as part of its ongoing commitment to address the gaps in care and...


Oct 13, 2011, 09:00 ET ViiV Healthcare's Positive Action for Children Fund Announces 16 New Grantees for the Year 2011/2012

ViiV Healthcare announced today that it has awarded approximately 3.9 million pounds Sterling to 16 organisations in eight countries, through its...


Oct 12, 2011, 19:07 ET 'ViiV Healthcare Effect' haucht den positiven Aktionspartnerschaften von ViiV Healthcare Leben ein

- Persönliche Geschichten, Lebenserfahrungen und Kooperationen auf neuer Website vorgestellt WAS: Der ViiV Healthcare Effect...


Oct 12, 2011, 18:55 ET 'ViiV Healthcare Effect' proporciona asociaciones de acción positivas para la vida de ViiV Healthcare

- La nueva página web muestra las historias personales, experiencias de la vida real y colaboraciones QUÉ: ViiV Healthcare...


Oct 12, 2011, 13:58 ET "ViiV Healthcare Effect"dá vida a parcerias da Ação Positiva da ViiV Healthcare

O QUE: O ViiV Healthcare Effect (www.ViiVHealthcareEffect.com) apresenta a abordagem de nossa empresa a parcerias, de uma forma única e...


Oct 12, 2011, 13:47 ET 'ViiV Healthcare Effect' donne vie aux partenariats Action positive de ViiV Healthcare

  - Un nouveau site Web présente des histoires personnelles, des expériences dans la vraie vie et des collaborations SUJET :...


Oct 12, 2011, 05:00 ET 'ViiV Healthcare Effect' hace realidad las asociaciones para la acción positiva de ViiV Healthcare

QUÉ: ViiV Healthcare Effect (www.ViiVHealthcareEffect.com) presenta el enfoque de nuestra compañía a las asociaciones de un...


Oct 12, 2011, 05:00 ET 'ViiV Healthcare Effect' Brings ViiV Healthcare's Positive Action Partnerships to Life

WHAT: The ViiV Healthcare Effect (www.ViiVHealthcareEffect.com) introduces our company's approach to partnerships in a unique and personal way....


Oct 11, 2011, 09:00 ET ViiV Healthcare Starts Phase III Clinical Programme of Celsentri/Selzentry® (maraviroc) versus Truvada® (tenofovir + FTC), in combination with a Protease Inhibitor in people living with HIV

ViiV Healthcare announces the start of the Phase III MODERN Study [Maraviroc Once daily with Darunavir Enhanced by Ritonavir in a Novel regimen],...


Oct 12, 2010, 09:00 ET ViiV Healthcare Acts to Improve Access to HIV Medicines in United States for Those Most in Need

ViiV Healthcare will expand its Patient Assistance Program effective January 1, 2011 and continue its Patient Savings Card program to help maintain...


Sep 09, 2010, 10:00 ET ViiV Healthcare Awards Southern Initiative Grants to Reduce HIV Disparities Among African Americans and Latinos

ViiV Healthcare today announced the grant awardees of the Positive Action Southern Initiative, focused on supporting African American and Latino...


Jul 06, 2010, 14:43 ET ViiV Healthcare Announces Positive Action U.S. Southern Initiative, an Innovative Community Support Program to Fight HIV/AIDS

ViiV Healthcare today announced the launch of Positive Action U.S. Southern Initiative, a collaborative, community-focused program designed to...